TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Trius Therapeutics, Inc. (NASDAQ:TSRX) Investor Investigation Concerning Possible Breaches Of Fiduciary Duties In Takeover By Cubist Pharmaceuticals

  • Investors who purchased shares of Trius Therapeutics, Inc. (NASDAQ:TSRX) prior to July 30 2013 , and currently hold any of those NASDAQ:TSRX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

August 1, 2013 (Shareholders Foundation) - An investigation on behalf of investors in Trius Therapeutics, Inc. (NASDAQ:TSRX) shares was announced concerning whether the offer by Cubist Pharmaceuticals to merge with Trius Therapeutics, Inc. for $13.50 per NASDAQ:TSRX share and the takeover process are unfair to investors in Trius Therapeutics shares. The investigation by a law firm co...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: